NASDAQ:IBB   ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND
99 1 3
Crab nearly completed. Candlestick makes me question if it will achieve target.
One thing I noticed about the IBB is that it corrected 10% unlike the overall market did. Short float is also 33%. GILD is also the heaviest weighted company within the IBB and it is trading very cheap to it's peers due to concern that profits may be limited to their current pipeline. If they acquire another company, which they probably will, GILD will soar taking IBB with it (Kind of like CELG did). I know this is a focus on technicals but may be something to consider :)
Reply
English
English (UK)
English (IN)
Deutsch
Français
Español
Italiano
Polski
Türkçe
Русский
Português
Bahasa Indonesia
Bahasa Melayu
ภาษาไทย
Tiếng Việt
日本語
한국어
简体
台灣
Home Stock Screener Forex Signal Finder Cryptocurrency Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out